| Serial Number | 88425671 |
| Word Mark | RENEW |
| Filing Date | Friday, May 10, 2019 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Monday, October 28, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Oils derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD for use as comestibles, namely, edible oil for cooking, edible oils and fats, processed oils for food; hemp related products, namely, oils for use as comestibles, namely, edible oil for cooking, edible oils and fats, processed oils for food solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; food products containing hemp, resins, and oils, namely, butter; all of the foregoing containing ingredients solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD |
| Goods and Services | medicated liquid soaps; disinfectant and anti-bacterial liquid soaps; medicated skin care preparations; Hemp related products, namely, medicinal oils solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; tinctures, tablets and capsules for treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders and anxiety; medicated oils, and concentrated pastes for the treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders, and anxiety; tinctures, tablets and capsules each containing resins and oils derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD for treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders and anxiety; nutraceuticals for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes containing derivatives of hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD, namely, resins and oils for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; medicated topical skin creams, medicated bar and liquid soaps; medicated bath additives, namely, bath herbs, bath oils, bath salts; medicated body creams, medicated body oils, medicated face and body lotions, medicated face and body milk, medicated face lotion, and medicated skin care preparations each of the foregoing containing derivatives of hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid; personal sexual lubricants; transdermal patches containing derivatives of hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oral sprays for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; hemp related products, namely, oils for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; oils derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; all of the foregoing containing ingredients solely derived from hemp with a delta- 9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD |
| Goods and Services | Smokers' articles, namely, grinders for use with hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; smokers' articles, namely, smoking pipes, oral vaporizers for smokers; all of the foregoing containing ingredients solely derived from hemp or exclusively for use with goods containing ingredients solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; smokers' articles, namely, pouches for use with hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD, lighters for smokers |
| International Class | 034 - Tobacco; smokers' articles; matches. |
| US Class Codes | 002, 008, 009, 017 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, May 28, 2019 |
| Primary Code | 034 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, May 28, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 029 - Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits and vegetables; jellies, jams, compotes; eggs, milk and milk products; edible oils and fats. |
| US Class Codes | 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, May 28, 2019 |
| Primary Code | 029 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Aphria Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Leamington N8H4H3 CA |
| Event Date | Event Description |
| Tuesday, May 14, 2019 | NEW APPLICATION ENTERED |
| Tuesday, May 28, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, May 30, 2019 | ASSIGNED TO EXAMINER |
| Monday, July 29, 2019 | LETTER OF PROTEST EVIDENCE FORWARDED |
| Tuesday, October 15, 2019 | ASSIGNED TO EXAMINER |
| Monday, October 21, 2019 | NON-FINAL ACTION WRITTEN |
| Monday, October 21, 2019 | NON-FINAL ACTION E-MAILED |
| Monday, October 21, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, April 21, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, April 21, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, April 22, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, April 27, 2020 | SUSPENSION LETTER WRITTEN |
| Monday, April 27, 2020 | LETTER OF SUSPENSION E-MAILED |
| Monday, April 27, 2020 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, October 27, 2020 | SUSPENSION INQUIRY WRITTEN |
| Tuesday, October 27, 2020 | INQUIRY TO SUSPENSION E-MAILED |
| Tuesday, October 27, 2020 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Friday, April 2, 2021 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Thursday, June 17, 2021 | ASSIGNED TO LIE |
| Friday, June 18, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, June 18, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, August 13, 2021 | NON-FINAL ACTION WRITTEN |
| Friday, August 13, 2021 | NON-FINAL ACTION E-MAILED |
| Friday, August 13, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, October 25, 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, October 25, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, October 25, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, October 25, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, October 25, 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, February 14, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, February 14, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, February 15, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, March 1, 2022 | ASSIGNED TO EXAMINER |
| Monday, April 18, 2022 | ASSIGNED TO EXAMINER |
| Monday, August 1, 2022 | NON-FINAL ACTION WRITTEN |
| Monday, August 1, 2022 | NON-FINAL ACTION E-MAILED |
| Monday, August 1, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, January 31, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, January 31, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, February 1, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, January 23, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, January 26, 2024 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Monday, February 5, 2024 | ELECTRONIC RECORD REVIEW COMPLETE |
| Tuesday, February 20, 2024 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Thursday, March 14, 2024 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Monday, October 28, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, October 28, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, October 28, 2024 | NON-FINAL ACTION WRITTEN |